The psychology of neurofeedback: Clinical intervention even if applied placebo.
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Advocates of neurofeedback make bold claims concerning brain regulation, treatment of disorders, and mental health. Decades of research and thousands of peer-reviewed publications support neurofeedback using electroencephalography (EEG-nf); yet, few experiments isolate the act of receiving feedback from a specific brain signal as a necessary precursor to obtain the purported benefits. Moreover, while psychosocial parameters including participant motivation and expectation, rather than neurobiological substrates, seem to fuel clinical improvement across a wide range of disorders, for-profit clinics continue to sprout across North America and Europe. Here, we highlight the tenuous evidence supporting EEG-nf and sketch out the weaknesses of this approach. We challenge classic arguments often articulated by proponents of EEG-nf and underscore how psychologists and mental health professionals stand to benefit from studying the ubiquitous placebo influences that likely drive these treatment outcomes. (PsycINFO Database Record
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816 · cited 2×
“…likely drives publication bias (Turner, Matthews, Linardatos, Tell, & Rosenthal, 2008) and encourages research designs that conflate the benefits of specific mechanism with psychosocial influences, thus inflating the literature with positive findings (Bekelman & Gross, 2003; Perlis et al., 2005).”
BackgroundResultFoxe, J. J., & Snyder, A. C. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00154 · Cited by 1,558 · cited 1×
“For example, while heightened alpha amplitude correlates with meditation (Lagopoulos et al., 2009), attentional suppression (Foxe & Snyder, 2011), working memory (Jensen, Gelfand, Kounios, & Lisman, 2002), eye closure (Barry, Clarke, Johnstone, Magee, & Rushby, 2007) and anxiety (Klimesch, Sauseng,…”
BackgroundHoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420 · cited 1×
“However, research on behavioral therapies often include placebo controls (e.g., Hofmann & Smits, 2008), cohorts are no more heterogeneous than in other clinical experiments and blinding individualized treatments is feasible, sham treatments represent standard clinical research practice, automatic…”
BackgroundSonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., Stevenson, J., Danckaerts, M., van der Oord, S., Döpfner, M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070991 · Cited by 1,167
A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought
Price, D. D., Finniss, D. G., & Benedetti, F. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.113006.095941 · Cited by 1,146
THE MECHANISM OF PLACEBO ANALGESIA
Levine, J., Gordon, N., & Fields, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92762-9 · Cited by 1,094
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
EEG differences between eyes-closed and eyes-open resting conditions
Barry, R. J., Clarke, A. R., Johnstone, S. J., Magee, C. A., & Rushby, J. A. (2007) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.07.028 · Cited by 1,077
Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors
Zubieta, J.-K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., Nichols, T. E., & Stohler, C. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0439-05.2005 · Cited by 779 · cited 1×
“T hi s ar tic le is in te nd ed so le ly fo r th e pe rs on al us e of th e in di vi du al us er an d is no t to be di ss em in at ed br oa dl y. Levine, Gordon, & Fields, 1978; ter Riet, De Craen, De Boer, & Kessels, 1998; Zubieta et al., 2005) and fMRI-indexed brain activity (Kong et al., 2006).”
The researcher's own therapy allegiances: A "wild card" in comparisons of treatment efficacy.
Luborsky, L., Diguer, L., Seligman, D. A., Rosenthal, R., Krause, E. D., Johnson, S., Halperin, G., Bishop, M., Berman, J. S., & Schweizer, E. (1999) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.6.1.95 · Cited by 572 · cited 1×
“Even in the absence of financial interest, moreover, comparative studies across behavioral treatment, psychotherapy, and pharmacology, tend to skew findings toward the specific choice-oftreatment espoused by the authors (Luborsky et al., 1999; Maj, 2008).”
ResultReal-time fMRI neurofeedback: Progress and challenges
Sulzer, J., Haller, S., Scharnowski, F., Weiskopf, N., Birbaumer, N., Blefari, M. L., Bruehl, A. B., Cohen, L. G., deCharms, R. C., Gassert, R., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.03.033 · Cited by 453 · cited 1×
“Similarly, findings from the bourgeoning field of fMRI-nf, where participants quickly learn to modulate precise hemodynamic brain signals, remain distinct from EEG-nf research (Sulzer et al., 2013).”
BackgroundEvaluation of neurofeedback in ADHD: The long and winding road
Arns, M., Heinrich, H., & Strehl, U. (2014) · Biological Psychology · doi:10.1016/j.biopsycho.2013.11.013 · Cited by 404
Kong, J., Gollub, R. L., Rosman, I. S., Webb, J. M., Vangel, M. G., Kirsch, I., & Kaptchuk, T. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3556-05.2006 · Cited by 395 · cited 2×
“T hi s ar tic le is in te nd ed so le ly fo r th e pe rs on al us e of th e in di vi du al us er an d is no t to be di ss em in at ed br oa dl y. Levine, Gordon, & Fields, 1978; ter Riet, De Craen, De Boer, & Kessels, 1998; Zubieta et al., 2005) and fMRI-indexed brain activity (Kong et al., 2006).”
Increased Theta and Alpha EEG Activity During Nondirective Meditation
Lagopoulos, J., Xu, J., Rasmussen, I., Vik, A., Malhi, G. S., Eliassen, C. F., Arntsen, I. E., Sæther, J. G., Hollup, S., Holen, A., et al. (2009) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0113 · Cited by 354 · cited 2×
“For example, while heightened alpha amplitude correlates with meditation (Lagopoulos et al., 2009), attentional suppression (Foxe & Snyder, 2011), working memory (Jensen, Gelfand, Kounios, & Lisman, 2002), eye closure (Barry, Clarke, Johnstone, Magee, & Rushby, 2007) and anxiety (Klimesch, Sauseng, & Hanslmayr, 2007),…”
BackgroundActivation of the reward system boosts innate and adaptive immunity
Ben-Shaanan, T. L., Azulay-Debby, H., Dubovik, T., Starosvetsky, E., Korin, B., Schiller, M., Green, N. L., Admon, Y., Hakim, F., Shen-Orr, S. S., et al. (2016) · Nature Medicine · doi:10.1038/nm.4133 · Cited by 272 · cited 1×
“Research further documents a range of placebo phenomena in nonhuman animals for a spectrum of objective measures, including antibody production (Ader, Kelly, Moynihan, Grota, & Cohen, 1993; Jæger, Larsen, & Moe, 2006; McMillan, 1999) and bacterial immunity (Ben-Shaanan et al., 2016).”
BackgroundThe self-regulating brain and neurofeedback: experimental science and clinical promise
Thibault, R. T., Lifshitz, M., & Raz, A. (2016) · Cortex · doi:10.1016/j.cortex.2015.10.024 · Cited by 272 · cited 6×
“Whereas all other clinical EEG-nf experiments employing double-blind, sham-controlled designs sought to treat ADHD (Thibault et al., 2016), a few oft-cited studies leverage alternative control methods and aim to treat refractory epilepsy (Kotchoubey et al., 2001; Lubar et al., 1981; Sterman &…”
BackgroundInfluentialSelf-citationGruzelier, J. H. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.015 · Cited by 270
Neurofeedback training in children with ADHD: 6-month follow-up of a randomised controlled trial
Gevensleben, H., Holl, B., Albrecht, B., Schlamp, D., Kratz, O., Studer, P., Rothenberger, A., Moll, G. H., & Heinrich, H. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0109-5 · Cited by 217 · cited 2×
“…hand, EEG-nf studies rarely report NNT or NNH, yet side effects remain mild and uncommon (Hammond & Kirk, 2008), and positive outcomes appear to persist well beyond the treatment period (Gani, Birbaumer, & Strehl, 2008; Gevensleben et al., 2010; Leins et al., 2007; Strehl, Leins, et al., 2006).”
BackgroundCheng, J. Y. W., Chen, R. Y. L., Ko, J. S. N., & Ng, E. M. L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0840-x · Cited by 185
Placebo effects and their determinants in gastrointestinal disorders
Elsenbruch, S., & Enck, P. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.117 · Cited by 173 · cited 1×
“…treatments that target brain function and behavior—from psychiatry (Weimer, Colloca, & Enck, 2015) to gastroenterology and the brain-gut axis (Elsenbruch & Enck, 2015)— derive substantial benefits from such psychosocial variables (e.g., see antidepressants in Kirsch, 2009; Kirsch et al.,…”
BackgroundZuberer, A., Brandeis, D., & Drechsler, R. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00135 · Cited by 113
Thibault, R. T., Lifshitz, M., Birbaumer, N., & Raz, A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371714 · Cited by 112 · cited 4×
“Notably, standard neurofeedback treatment often comprises 40 sessions and costs between $4,000 and $10,000 USD (Thibault et al., 2015).”
BackgroundInfluentialSelf-citationConflicts of interest and spin in reviews of psychological therapies: a systematic review
Lieb, K., Osten-Sacken, J. V. D., Stoffers-Winterling, J., Reiss, N., & Barth, J. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010606 · Cited by 69
Rains, J. C., & Penzien, D. B. (2005) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.05099.x · Cited by 63 · cited 1×
“…introduction of sham biofeedback often demonstrates equivalence between veridical and placebo biofeedback (e.g., Andrasik & Holroyd, 1980, 1983; Hunyor et al., 1997; Mullinix, Norton, Hack, & Fishman, 1978; Nicassio, Boylan, & McCabe, 1982; Plotkin & Rice, 1981; Rains & Penzien, 2005; Rains, 2008).”
Cited by
Ros, T., Enriquez-Geppert, S., Zotev, V., Young, K. D., Wood, G., Whitfield-Gabrieli, S., Wan, F., Vuilleumier, P., Vialatte, F., Van De Ville, D., et al. (2020) · Brain · doi:10.1093/brain/awaa009 · Cited by 399
Self-citationRubia, K., Criaud, M., Wulff, M., Alegria, A., Brinson, H., Barker, G., Stahl, D., & Giampietro, V. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2018.11.055 · Cited by 111
“However, recent meta-analyses and reviews of randomized controlled trials of EEG-Neurofeedback of “probably” blinded raters show only trend-level improvements (Holtmann et al., 2014; Thibault and Raz, 2017).”
Fruchtman-Steinbok, T., Keynan, J. N., Cohen, A., Jaljuli, I., Mermelstein, S., Drori, G., Routledge, E., Krasnoshtein, M., Playle, R., Linden, D. E. J., et al. (2021) · NeuroImage: Clinical · doi:10.1016/j.nicl.2021.102859 · Cited by 42
Noisy but not placebo: defining metrics for effects of neurofeedback
Witte, M., Kober, S. E., & Wood, G. (2018) · Brain · doi:10.1093/brain/awy060 · Cited by 36
Perez, T. M., Glue, P., Adhia, D. B., Navid, M. S., Zeng, J., Dillingham, P., Smith, M., Niazi, I. K., Young, C. K., & De Ridder, D. (2022) · Trials · doi:10.1186/s13063-022-06863-z · Cited by 8
Metadata
- Authors
- Thibault, R. T., & Raz, A.
- Venue
- American Psychologist
- Published
- 2017-10
- Volume
- 72
- Issue
- 7
- Pages
- 679-688
- ISSN
- 0003-066X (ISSN-L)
- 1935-990X
- OpenAlex
- W2761356936
- Cited by
- 127
- References
- 25
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.